Approval · Notice of Compliance 18802 · 2016
FERRLECIT: Notice of Compliance 18802
Issued December 20, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18802
- Date
- December 20, 2016
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the storage conditions for the drug product; provide for increase in shelf life of the vial presentation; and update the cpid-ce product monograph and labels with this new information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FERRLECIT | Not yet assigned | — |
Medicinal ingredients
- SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION 12.5 MG per ML